Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Rating) – Stock analysts at Leede Jones Gab reduced their FY2022 EPS estimates for shares of Cardiol Therapeutics in a research report issued on Wednesday, August 3rd. Leede Jones Gab analyst D. Loe now expects that the company will post earnings of ($0.24) per share for the year, down […]
